Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Escitalopram Assay Design: From 5-HTT to Translation
2026-09-09
Escitalopram research is strongest when transporter potency, assay context, and clinical moderators are interpreted together. This guide connects Lexapro pharmacology with practical 5-HT reuptake inhibition workflows and the limitations of augmentation evidence.
Thiothixene: Neuroimmune Assay Workflows
2026-09-08
Thiothixene supports a practical bridge between dopamine receptor pharmacology and in vitro macrophage efferocytosis enhancement. This guide translates its Stra6l–vitamin A–arginase 1 biology into reproducible assay steps while keeping schizophrenia treatment and FGFR1-related findings appropriately distinct.
Dasatinib: From Kinase Signals to Tumor State
2026-09-08
Dasatinib (BMS-354825) is more than a Bcr-Abl research tool. Its Src-family kinase activity creates a framework for connecting phosphorylation events with EMT, stemness, adhesion, invasion, and metastatic behavior—while the SNAI1–PIK3R2/p-EphA2 study shows why pathway and cell-state measurements must be interpreted together.
Tropisetron Hydrochloride: Applied Assay Guide
2026-09-07
Tropisetron Hydrochloride supports integrated studies of 5-HT3 receptor signaling, α7-nicotinic receptor activity, and renal organic-cation transport. This workflow-centered guide shows how to pair receptor assays with OCT2/MATE1 models while avoiding concentration, solubility, and cell-system artifacts.
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-09-07
Borchert et al. linked homologous recombination repair defects, or BRCAness, with olaparib sensitivity in malignant pleural mesothelioma, particularly in BAP1-mutated models. Their combination of drug-response experiments and clinical-sample gene-expression profiling provides a useful framework for biomarker-guided cancer chemotherapy research while emphasizing the need for prospective validation.
Recombinant Human FGF-19: Applied Assay Workflows
2026-09-05
Build more reproducible receptor-binding, proliferation, and metabolic signaling experiments with a validated, tag-free FGF-19 reagent. This guide connects practical protein handling to exploratory studies of FGFR4 signaling and the WIP1–p38 MAPK–pyroptosis axis in renal injury.
D-N-Acetylgalactosamine: Lab Guide
2026-09-04
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity carbohydrate metabolite for aqueous or DMSO-based work involving glycoprotein composition and glycosylation pathway studies. It should not be selected for ethanol-based protocols or long-term storage of working solutions.
Escitalopram Workflows for Anxious Depression
2026-09-04
Build reproducible serotonergic assays around Escitalopram, from transporter occupancy and 5-HT reuptake inhibition to anxiety-relevant phenotyping. A reference-study translation shows how subgroup stratification and orthogonal endpoints can distinguish target engagement from clinically meaningful behavioral effects.
Zolmitriptan: From Receptor Biology to Translation
2026-09-03
Zolmitriptan is more than a familiar serotonergic tool: it is a precise entry point for studying receptor-driven vascular and neuropeptide biology in migraine and cluster headache models. This thought-leadership analysis outlines how to build stronger assays around a 5-HT1B receptor agonist, use lysosomal biology as a carefully bounded cross-domain lens, and convert compound handling, mechanistic validation, and translational decision gates into a more reliable research strategy.
Levofloxacin: From DNA Gyrase to Translation
2026-09-03
A translational framework for using Levofloxacin to connect bacterial DNA replication, antimicrobial resistance surveillance, and bone and cartilage cell biology.
Trelagliptin, RUNX2, and Osteoblastic Differentiation
2026-09-02
The reference study identifies a potential bone-forming action of the DPP-4 inhibitor trelagliptin in MC3T3-E1 osteoblastic cells, linking treatment to AMPK activation, RUNX2 upregulation, and enhanced mineralization. Its findings provide a mechanistic starting point for osteoporosis research, while the in vitro design requires validation in primary cells and animal models.
LNP-mRNA Fibroblasts for Intervertebral Disc Degeneration
2026-09-02
A 2026 Chemical Engineering Journal study developed fibroblasts engineered with lipid nanoparticle-delivered mRNA to produce TNF-α-neutralizing antibodies in degenerating intervertebral discs. The approach combines a local cell-based depot with transient mRNA delivery, reducing inflammatory injury and improving disc structure in a rat model while leaving important translational questions unresolved.
Palonosetron hydrochloride: 5-HT3 Assay Workflows
2026-09-01
Build reproducible 5-HT3A/5-HT3AB receptor assays, transporter studies, and translational antiemetic experiments around a highly selective reference compound. This guide connects low-nanomolar receptor pharmacology with OCT2/MATE1 inhibition while emphasizing controls, dosing logic, and troubleshooting.
Perospirone Workflows for Receptor and Kv1.5 Studies
2026-09-01
Build receptor-based schizophrenia research assays and vascular ion-channel workflows around Perospirone, also known as SM-9018 free base. Its established 5-HT2A, D2, and 5-HT1A pharmacology now pairs with a reported Kv1.5-linked coronary smooth-muscle effect, enabling a practical cross-domain safety screen.
Mianserin HCl: From Receptors to Assay Design
2026-08-31
Mianserin HCl is more than a 5-HT2 receptor antagonist: its cyclodextrin chemistry can change how biological data should be interpreted. This article connects receptor pharmacology, host–guest complexation, cytotoxicity, and assay design for more rigorous neuroscience research.
8029 records 9/536 page Previous Next First page 上5页 678910 下5页 Last page